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The basic helix–loop–helix transcription factor Twist1 is a key regulator of craniofacial development.
Twist1-null mouse embryos exhibit failure of cephalic neural tube closure and abnormal head
development and die at E11.0. To dissect the function of Twist1 in the cranial mesoderm beyond
mid-gestation, we used Mesp1-Cre to delete Twist1 in the anterior mesoderm, which includes the
progenitors of the cranial mesoderm. Deletion of Twist1 in mesoderm cells resulted in loss and
malformations of the cranial mesoderm-derived skeleton. Loss of Twist1 in the mesoderm also resulted
in a failure to fully segregate the mesoderm and the neural crest cells, and the malformation of some
cranial neural crest-derived tissues. The development of extraocular muscles was compromised
whereas the differentiation of branchial arch muscles was not affected, indicating a differential
requirement for Twist1 in these two types of craniofacial muscle. A striking effect of the loss of Twist1
was the inability of the mesodermal cells to maintain their mesenchymal characteristics, and the
acquisition of an epithelial-like morphology. Our ﬁndings point to a role of Twist1 in maintaining the
mesenchyme architecture and the progenitor state of the mesoderm, as well as mediating mesoderm–
neural crest interactions in craniofacial development.
& 2012 Elsevier Inc. All rights reserved.Introduction
Craniofacial structures are derived from the cranial neural crest
(CNC) and the cranial mesoderm (CM) (Bronner and Ledouarin, 2012;
Couly et al., 1992; Kontges and Lumsden, 1996; Minoux and Rijli,
2010; Noden and Francis-West, 2006; Sauka-Spengler and Bronner-
Fraser, 2006). The CNC cells, a population of migratory cells arising
from the lateral region of the neural folds, contribute to all the
elements of the viscerocranium (comprised of the lower jaw, upper
jaw and snout), the frontal bones of the skull and the anterior skull
base, as well as the connective tissues, cranial ganglia and the smooth
muscle of the blood vessels in the head. The CM, which is part of the
mesoderm layer formed during gastrulation, contributes to the
muscles of the face and neck, endothelial cells of the blood vessels,
and bones of the neurocranium and the posterior skull base (Noden
and Francis-West, 2006; Saga et al., 1999; Sambasivan et al., 2011;ll rights reserved.
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45, Australia.Yoshida et al., 2008). The CM can be subdivided topographically into
the prechordal, cranial paraxial and cranial lateral populations, all of
which contribute to the craniofacial muscles. Cell transplantation and
lineage tracing experiments performed on avian embryos show that
the prechordal and rostral parts of the cranial paraxial mesoderm
contain the precursors of the extraocular muscles (Couly et al., 1992)
while the lateral part of the cranial mesoderm contributes to the
muscles of the branchial arches. However, genetic lineage tracing
studies in mouse embryos have revealed a clonal relationship
between some cells of the extraocular muscles and the mandibular
arch-derived muscles, suggesting that they are not derived from
entirely separate lineages (Lescroart et al., 2010).
Twist1 encodes a basic helix–loop–helix transcription factor that is
expressed in both the CNC and the CM during craniofacial develop-
ment (Fuchtbauer, 1995; Stoetzel et al., 1995). In humans, haploin-
sufﬁciency of TWIST1 is associated with the autosomal dominant
Saethre–Chotzen syndrome (SCS) (El Ghouzzi et al., 1997; Qin et al.,
2012; Rose and Malcolm, 1997), characterized by a varied pattern of
craniofacial defects including craniosynostosis, ptosis and facial
asymmetry. In Drosophila, loss of twist leads to abnormal gastrulation
and failure of mesoderm formation (Thisse et al., 1987), pointing to
a function in eliciting epithelial–mesenchymal transition (EMT).
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defects including a failure to close the cranial neural tube, branchial
arch hypoplasia, poor vascular development and the demise of the
embryo at around embryonic day (E) 11 (Chen and Behringer, 1995).
The embryonic lethality of the Twist1-null mutation does not
allow analysis of Twist1 function in craniofacial development beyond
mid-gestation. This obstacle can be overcome by conditional ablation
of Twist1 in speciﬁc tissues, which minimizes the impact of loss of
gene function on the viability of the embryo (Chen et al., 2007). Using
this approach we have shown that loss of Twist1 in the CNC cells
leads to reduced cell viability and impaired differentiation, loss or
malformation of CNC-derived skeleton, poor frontonasal development
and mandibular hypoplasia (Bildsoe et al., 2009). In addition, the
formation the parietal and interparietal bones, which are derived
from the CM, is also affected, suggesting that the CNC-derived tissues
may play a supportive role in the development of some mesodermal
bones.
To investigate the role of Twist1 in the cranial mesoderm, a
similar conditional ablation strategy was employed to eliminate
Twist1 activity by expressing Cre-recombinase in the nascent
mesoderm during gastrulation, via a Cre transgene insertion into
the Mesp1 locus (Loebel et al., 2012; Saga et al., 1999). In this
study, Twist1 activity in the cranial mesoderm is shown to be
essential for normal development of the mesoderm-derived
components of the neurocranium and the formation of the
extraocular muscles. We have also uncovered an unexpected
effect of the loss of Twist1 on the ability of the CM cells to
maintain their mesenchymal characteristics, resulting in the
acquisition of an epithelial phenotype.Material and methods
Mouse strains and genotyping : Twist13loxPneo/3loxPneo and Twist1del/þ
mice were maintained and genotyped as previously described
(Bildsoe et al., 2009; Chen et al., 2007). Mesp1-Cre mice (Saga et al.,
1999) were maintained on a C57BL/6 background.
Crosses were performed as previously described (Loebel et al.,
2012). We ﬁrst crossed Mesp1-Cre mice (Saga et al., 1999) to
Twist1del/þ mice to generate Twist1del/þ;MespCre/þ mice. To generate
embryos with a mesoderm-speciﬁc Twist1 deﬁciency, Twist1del/þ ;
Mesp1Cre/þ mice were crossed with Twist13loxPneo/3loxPneo mice. Con-
ditional knockout (CM–CKO) embryos of Twist13loxPneo/del;Mesp1Cre/þ
genotype, wild-type (WT) Twist13loxPneo/þ , Mesp1þ /þ , and hetero-
zygous Twist13loxPneo/del; Mesp1þ /þ or Twist13loxPneo/del; Mesp1þ /Cre
embryos were collected for phenotypic analysis.
To trace the distribution of the descendents of Mesp1-Cre
expressing cells, mice carrying the Rosa26R allele (Soriano, 1999)
the Twist13loxPneo/3loxPneo (Loebel et al., 2012) and Mesp1Cre/þ alleles
were crossed to generate embryos in which Mesp1-Cre activity will
activate the lacZ reporter in the wild type cells and also excise the
ﬂoxed Twist1 allele such that Twist1-CKO cells can be tracked by
lacZ expression.
Trp53 mutant mice (#002101), obtained from the Jackson
Laboratory (Jacks et al., 1994), were crossed with Twist1-del mice
(Bildsoe et al., 2009) to generate double heterozygous mice. These
mice were crossed together and embryos with various combina-
tions of Twist1 and Trp53 alleles collected at E9.5-E10.5. Mice and
embryos were genotyped for Twist1 and Trp53 as described
(Bildsoe et al., 2009; Chen et al., 2007; Jacks et al., 1994).
Bone and cartilage staining
Embryos were collected between E15.5 and E17.5 in PB1 and
rinsed in cold PBS. Bone and cartilage was stained with alizarin red
and alcian blue as previously described (Bildsoe et al., 2009; Hoganet al., 1994; Loebel et al., 2012). Stained specimens were washed,
stored and photographed in aqueous 20% ethanol: 20% glycerol.
Images were captured using a SPOT camera (SciTech) and Leica
microscope.
b-galactosidase reporter staining
Embryos between E 7.5–11.5 were stained as whole mount
specimens as described (Loebel et al., 2012;Watson et al., 2008).
Brieﬂy embryos were collected in PB1 media and rinsed in cold
calcium- and magnesium-free PBS before ﬁxing for a minimum of
2 h at 4 1C in glutaraldehyde ﬁxative. After ﬁxation the embryos
were rinsed in X-gal washing buffer brieﬂy and incubated in the
X-gal staining solution at 37 1C for 2–6 h for color development.
The embryos were washed twice in X-gal washing buffer, then in
PBS and ﬁxed in 4% PFA.
For staining of cryosections, heads of E13.5 and E15.5 embryos
were dissected in PB1 medium, rinsed in calcium–magnesium
free PBS and ﬁxed on ice (Mani et al., 2010;Rivera-Perez et al.,
1999). The heads were dehydrated in 10% sucrose/PBS overnight
at 4 1C, followed by 25% sucrose/PBS overnight at 4 1C. Tissues
were embedded in 25% sucrose/PBS:OCT (Tissue Tek) embedding
medium (2:1). Sections were cut at 5–9 mm on a cryostat (M1900,
Lexica), collected on Super frost Plus slides (Mensal-Glaser) and
stored at 80 1C until needed. Sections were thawed at room
temperature, rinsed in X-gal washing buffer three times and then
incubated in the X-gal staining solution at 37 1C overnight for
color development (Watson et al., 2008). Sections were washed in
the X-gal washing buffer and water, and counterstained with
nuclear fast red and mounted in Ultra-mount No.4 (Fronine).
In situ hybridization
Embryos from E7.5–11.5 were dissected in PB1, rinsed in cold
PBS and ﬁxed in 4% PFA. Automated whole mount in situ
hybridization was carried out using an InsituPro machine (Intavis
AG) (Bildsoe et al., 2009;Loebel et al., 2004). Stained embryos
were washed in 0.1% Tween20 in H2O, ﬁxed in 4% PFA and
photographed. Probes to detect the following transcripts were
used: Cre (Loebel et al., 2012), Myf5, Pitx2, Sox10, Tbx1 and Twist1.
Embryos were imaged using a Leica dissecting microscope and
SPOT digital camera (SciTech).
Cell death analysis
Apoptotic cells were detected by whole mount TUNEL staining
with the ApopTag Plus Peroxidase In situ Apoptosis kit (Millipore)
as previously described (Martinez-Barbera et al., 2002). Embryos
were dissected in PB1, rinsed in cold PBS and ﬁxed in 4% PFA
overnight at 4 1C, and incubated in blocking buffer containing 2%
blocking reagent (Roche) and 20% heat inactivated fetal calf serum
in PBS/0.1% Tween. After antibody labeling, embryos were washed
overnight at 4 1C in 2 mg/ml BSA in PBS, 0.1% Tween with at least
four changes of buffer. After treatment, embryos were ﬁxed in 4%
PFA and the embryos were imaged using a Leica microscope and
SPOT digital camera (SciTech).
Histology
Embryos at E8.5–E15.5 were collected in PB1 and rinsed in
cold PBS, followed by ﬁxation in 4% PFA. For wax embedding, the
embryos were dehydrated stepwise through an ethanol series
(30%, 50%, 70%, 80%, 90% and 100%), cleared in xylene and
embedded in parafﬁn wax. Serial sections cut at 5–10 mm were
stained with haematoxylin and eosin.
Fig. 1. Expression of theMesp1-Cre transgene andmesoderm-speciﬁc ablation of Twist1. (A) In situ hybridization showingMesp1-Cre transcript expression in the nascent mesoderm.
(B) Whole mount stained embryo showing distribution of Mesp1-Cre; Rosa26R positive cells in an E7.5 embryo. (Bi) Histology of age-matched E7.5 embryos showing Rosa26R-
positive cells populating the entire mesoderm layer (plane of sectioning of Bi is shown in B). (C–E) Histological sections showing detection of Twist1 transcript by in situ
hybridization. (C) At E7.5 Twist1 transcript expression overlaps with the distribution of Rosa26R-positive mesodermal cells shown in (B). (D) At headfold stage (E8.0) Twist1
expression is detected in the cranial mesoderm underlying the neural epithelium (E: magniﬁcation of boxed area in D). (F) Expression of Twist1 protein in the same region at
headfold stage. The midline is to the right in E and F. (G,H) Twist1 protein is expressed in the cranial mesoderm of E8.5 control embryo (G) but absent in the CM–CKO (cranial
mesoderm conditional Twist1 knockout) embryo (H), (White asterisk: nonspeciﬁc staining in the endoderm). (I–L) Twist1 expression in the cranial mesenchyme of control embryo at
E9.5 (I, Ii and K) is absent in the CM–CKO (J, Ji and L). Corresponding regions in control and CM–CKO embryo are marked by the dashed line (K and L). The Twist1-deﬁcient cranial
mesenchyme displays early signs of acquiring a compacted morphology (L, red arrow). I and J: whole mount, Ii and Ji: sections of embryo at the plane (i) indicated in (I) and (J).
Boxed areas K and L are magniﬁed views of Ii and Ji. (M–O) Distribution ofMesp1-Cre; Rosa26R positive cells in the craniofacial region at E9.5 and E15.5. At E9.5Mesp1-Cre; Rosa26R
positive cells are observed in the paraxial regions of the cranial mesenchyme and in the core of the mandibular arch of the control embryo (M, whole mount, Mi, Mii: sections of the
embryo at planes marked by i and ii in M), and in the craniofacial muscles in the peri-ocular, facial, jaw and tongue region and the skeletal elements of the chondrocranium of E15.5
embryo (N and O; arrowheads marks the extraocular muscles in N). Abbreviations: ba1, branchial arch 1; ba2, branchial arch 2; bo, basioccipital bone; br, brain; cm, cranial
mesoderm; e, eye; el, eyelid; fb, forebrain; fg, foregut; ma, masseter muscle; md, mandible; mx, maxilla; nc, nasal cartilage; ne, neural epithelium; nt, neural tube; ov, optic vesicle;
pl, palate; ps, primitive streak; sq, squamous part of the temporal bone (tb); t, tongue. Scale bar¼100 mm.
H. Bildsoe et al. / Developmental Biology 374 (2013) 295–307 297
H. Bildsoe et al. / Developmental Biology 374 (2013) 295–307298Immunoﬂuorescence
Embryos at E8.0–E17.5 were ﬁxed in 4% PFA for 1–24 h at 4 1C.
Prior to staining the embryos were embedded in OTC solution,
sectioned at 9–12 mm and stored at 80 1C. Slides were thawed
at room temperature (RT) and permeablised using PBS, 0.1% BSA
and 0.02% Triton followed by three washes with washing solution
(PBS, 0.1% BSA, and 0.1% Tween) and blocked (PBS, 0.1% BSA, 0.1%
Tween and 5–10% serum) for at least 1 h at RT. Slides were
incubated with primary antibody in blocking solution overnight
at 4 1C and washed 35 min in washing solution before adding
secondary antibody in blocking solution and incubating for 1–2 h
at RT. For F-actin staining, Alexa594 conjugated phalloidin
(8 ml/ml, Molecular Probes) was added to blocking solution after
secondary antibody incubation and the sections were incubated
for 30 min, then washed in 25 min PBS, stained with DAPI and
mounted in DABCO. Primary antibodies for speciﬁc factors used in
this study were: myosin heavy chain (mf20, 1:20 dilution, Devel-
opmental Studies Hybridoma Bank, University of Iowa), Twist1
(1:50 dilution, Abcam), Ki67 (1/200, Abcam) E-cadherin (1/200
dilution, Life Technologies) and b-galactosidase (1/100, Abcam).
Secondary antibodies used were goat anti-rat DyLight 488
(1/600 dilution, Thermo Scientiﬁc), donkey anti-mouse conju-
gated to Alexa594 or 488 (1:400 Jackson ImmunoResearch) and
donkey anti-chicken conjugated to Alexa594 (1/500 Jackson
ImmunoResearch).qRT–PCR analysis
Total RNA was isolated from heads of E8.5, 9.5 and E10.5
embryos using an RNeasy Micro Kit (QIAGEN) according to the
manufacturer’s instructions. The RNA samples were reverse
transcribed into cDNA using Superscript III First-Strand Synthesis
System (Invitrogen) according to manufacturer’s instructions.
Quantitative RT–PCR was performed on Corbett Rotor-Gene
Thermocyclers (QIAGEN) using Platinum Taq (Invitrogen) and
SYBR Green I (Molecular Probes) with Polr2a or Tbp as the
reference gene. The following primers were used:Fig. 2. Formation of the craniofacial skeleton in the CM–CKO mutants. (A-Bi)Pitx2 forward; 50-gctggaagccactttccagagaaa- 30
Pitx2 reverse; 50–tggacagagacgctgacgtgag-30
Tbp forward: 50-tctggaaaagttgtattaacag-30
Tbp reverse: 50-gctgcagggtgatttcagt-30
Pdgfra forward: 50-gaggataagctgaaggactgggaagg-30
Pdgrfa reverse: 50-tactggaacctgtctcgatggcact-30
Snai2 forward: 50-cacacattgccttgtgtctgcaagat
Snai2 reverse: 50-atcagagtgggtctgcagatgtgcc
Vim forward:50-tgtacgaggaggagatgcggga-30
Vim reverse: 50-tgtctgaatgactgcagggtgcttt-30
Polr2a forward: 50-gcaccacgtccaatgatat-30
Polr2a reverse: 50-gtgcggctgcttccataa-30Lineage tracing of the skeletogenic CM progenitors. The Mesp1-Cre; Rosa26R
expressing mesodermal cells contribute to the skeletal elements of the base of
neurocranium, the craniofacial and tongue muscles and the blood vessels in the
E13.5 control embryos (Ai: section of embryo at the plane i indicated in A) but are
found in ectopic compact masses (red arrows) in the lateral region underneath the
open neural tube and sparsely in the craniofacial and tongue muscle and blood
vessels in the E13.5 CM–CKO embryo (Bi: section of the embryo at plane i indicated
in B). (C–H) Skeletal preparations of the skull vault and base. The E17.5 CM–CKO
embryos (D, F, H) show loss of skeletal elements in the vault and the base of the skull
when compared to control embryos (C, E and G). Dashed circles in H indicate the
expected location of the missing hypochiasmatic cartilage. bo, basi-occipital; br,
brain; bs, basisphenoid; e, eye; eo, exoccipital; ep, ear pinna; f, frontal; hc,
hypochiasmatic cartilage; ip, interparietal; md, mandible; mx, maxilla; n, nasal
bone; nc, nasal cartilage; oc, orbital cartilage; p, parietal; pp, parietal plate; ps,
presphenoid; so, supra-occipital; sq, squamosal bone; sv, skull vault; t, tongue and
tg, trigeminal ganglion; C and D: lateral view; E and F: ventral view with mandible
removed, G and H: dorsal view with skull vault removed. Scale bar¼100 mm.Results
Conditional ablation of Twist1 in the cranial mesoderm
To investigate the impact of loss of Twist1 function in the
cranial mesoderm tissues, Cre-recombinase expressed from the
Mesp1 locus was used to ablate a ﬂoxed allele of Twist1 during
mesoderm development (Loebel et al., 2012). Cre transcripts were
detected by in situ hybridization in the nascent mesoderm
localized next to the primitive streak of the gastrulating embryo
[Fig. 1A, see also Loebel et al., (2012)]. In Mesp1cre/þ; Rosa26R
embryos, b-galactosidase positive cells populated the whole
mesoderm layer of E7.5 embryo but not the other germ layers
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revealed that Twist1 mRNA was detected in the anterior-most
mesoderm population (which contains the precursors of the
cranial mesoderm) underlying the anterior ectoderm but were
absent from the primitive streak and nascent mesoderm
[Fig. 1C, see also Fuchtbauer, (1995)]. Taken together, the over-
lapping pattern of b-galactosidase reporter activity and Twist1
expression in the mesoderm suggests that Mesp1-Cre activity
would have ablated Twist1 in the precursors of the cranial
mesoderm.
In headfold stage embryos, Twist1 mRNAs were detected by
in situ hybridization in the mesoderm beneath the cephalic neural
folds (Fig. 1D and E). Nuclear localized Twist1 protein was
detected in the cranial mesoderm at E8.0 (two somite stage,
Fig. 1F), which is slightly earlier than E8.25 as previously reported
(Gitelman, 1997). In contrast to the widespread presence of
Twist1 protein in the cranial mesenchyme of E8.5 control (Twis-
t13loxPneo/wt, Mesp1Cre/þ) embryo (Fig. 1G), Twist1 was absent
from the corresponding regions of age-matched Twist1 condi-
tional mutant embryos (Twist13loxPneo/del, Mesp1Cre/þ¼CM–CKO;
Fig. 1H, n¼3). Whole mount staining and histological sections of
E9.5 CM–CKO embryos showed that Twist1 transcripts were not
detectable in tissues that were populated by Rosa26R-positive
cells (Fig. 1I–M), but were expressed by tissues in the Rosa26R-
negative regions that were populated by the CNC cells, such as the
lateral subectodermal mesenchyme, the branchial arches and the
frontonasal tissues (data not shown). Mesp1-Cre was therefore
effective for ablating Twist1 in the cranial mesoderm.
Mesodermal contribution to the craniofacial tissues
At E9.5, b-galactosidase positive cells fromMesp1Cre/þ; Rosa26R
embryos were found widely in the craniofacial mesenchyme
caudal to the optic vesicles (Fig. 1M, Mi, Mii). Mesenchymal cells
in this region that were negative for b-galactosidase activity are
likely to be descendants of CNC cells (Yoshida et al., 2008), while
b-galactosidase positive cells that were scattered in the unstained
anterior craniofacial mesenchyme have previously been identiﬁed
as endothelial cell progenitors (Yoshida et al., 2008). Caudal to the
optic vesicle, the b-galactosidase positive cells made up the
majority of the mesenchymal tissues surrounding the neural tube
but did not contribute to tissues in the lateral part of the maxillary
eminences (Fig. 1Mii). In the mandibular arch, Mesp1Cre/þ;
Rosa26R-positive cells were localized in the core of the arch
(Fig. 1Mii). At E15.5, b-galactosidase positive cells were found in
mesoderm-derived tissues including the muscles of the tongue,
jaws and neck, the extra ocular muscle (EOM), the endothelial
cells and the skull vault and base (Fig. 1N and O).
Disrupted development of the skull vault and base in CM–CKO
embryos
Loss of Twist1 in the mesoderm led to a severe disruption of
skull development. The neural crest-derived frontonasal structures
and the jaws were formed, but other parts of the skull were
missing and the embryo displayed exencephaly at E13.5 (Fig. 2A
and B, n¼4). The CM–CKO embryos completely lacked the normal
encasing of the brain as observed in the control embryo (Twis-
t13loxPneo/þ , Mesp1Cre/þ , Rosa26R; Fig. 2A, B; Supplementary
Fig. S1A, B). In control embryos, b-galactosidase positive cranial
mesoderm-derived cells were located in the posterior part of the
skull vault, whereas the b-galactosidase negative, presumed CNC-
derived cells were found in the frontal bones of the skull vault,
the upper and lower jaws and the frontonasal tissues (Fig. 2A).
In CM–CKO embryos (Twist13loxPneo/del, Mesp1cre/þ , Rosa26R) the
b-galactosidase positive cells did not locate to the correct position.Instead, b-galactosidase-positive cells congregated ectopically at
sites lateral to the CNC-derived presphenoid bone (Fig. 2Bi). The
skulls of CM–CKO embryos were consistently smaller than those
of control embryos (n¼3 each) and most of the skull vault was
missing (Fig. 2C, D). The mesoderm-derived parietal, interparietal
and supraoccipital bones were absent and the CNC-derived frontal
bones were reduced to small remnants located near the eyes
(n¼3, Fig. 2D). The nasal cartilage was foreshortened and the nasal
bone was smaller in CM–CKO embryos compared to the controls
(Twist13loxPneo/þ). The maxilla and mandible were formed but
reduced in size. The parietal plate, which intercalated between
the squamous bone and the exoccipital bone was small and
deformed (Fig. 2D). Formation of the skull base was also affected
(Fig. 2E, F). The mesoderm-derived basioccipital bone made up a
much smaller proportion of the skull base (Fig. 2E, F). The rostral
part of this bone protruded dorsally and did not align with the
skull base (Fig. 2D, black arrowhead; Supplementary Fig. S1A–D)
and ectopic cartilaginous elements were found adjacent to the
temporal bone (Supplementary Fig. S1Aii and Bii). In the peri-
ocular region of the skull base the mesoderm-derived hypochias-
matic cartilage (McBratney-Owen et al., 2008), a skeletal element
that is part of the presphenoid bone, was missing in the CM–CKO
embryo (Fig. 2G, H). The CNC-derived elements in the skull base,
including the presphenoid, basisphenoid and temporal bones were
present but generally smaller (Fig. 2E, F).
Abnormal development of peri-ocular structures in CM–CKO embryos
In addition to the loss of the hypochiasmatic cartilage
(Fig. 2H), the formation of the extraocular muscles (EOM) and
upper eyelid was impaired (Fig. 3A–D). Anti-myosin heavy chain
(MHC) immunoﬂuorescence of E15.5 CM–CKO (n¼2) and control
(n¼2) embryos and histology of E17.5 CM–CKO (n¼2), and
control embryos (n¼1) revealed that EOM were missing or
severely reduced in CM–CKO mutants (Fig. 3A D). All EOM groups
appeared to be equally affected, as we did not detect any
difference in the severity of the defect in the different EOMs.
Quantitative RT–PCR of Pitx2, an early marker of the viability and
myogenic property of the EOM progenitors (Zacharias et al.,
2011), revealed that its expression was signiﬁcantly reduced
(P¼0.03, n¼3) in the CM–CKO head tissues compared to wild
type and the heterozygous counterparts (Supplementary Fig. S2,
n¼3). Consistent with this, Pitx2 expression was not detected by
in situ hybridization in the mesenchyme ventral to the eye that
normally contains the EOM progenitors in E10.5 CM–CKO
embryos (Fig. 3E, F, n¼3). In contrast, Pitx2 expression in the
myogenic tissues of the ﬁrst and second branchial arches was
maintained (Fig. 3G and H). At E11.5, a muscle condensation in
the peri-ocular region that was visible in the control embryos
(Twist13loxPneo/wt, Mesp1Cre/þ , Rosa26R; Fig. 3I) was absent in the
Mesp1Cre/þ; Rosa26R positive CM–CKO embryos (Fig. 3J, n¼2).
The early loss of Pitx2 expression and the absence of muscle
condensation were most probably due to the lack of EOM
progenitors in the peri-ocular tissue of the CM–CKO embryos.
The formation of eyelids was affected by the loss of Twist1 in
the CM (Fig. 3A, B). At E11.0 CM derived b-galactosidase positive
mesenchyme, labeled by Mesp1-Cre was found dorsal to the
developing eye whereas Wnt1-Cre labeled CNC-derived mesench-
yme was located ventral to the eye primordia (Fig.3K and L) and
they contributed to dorsal and ventral eyelid tissues at 13.5
respectively (Fig. 3M and N). However, in the E13.5 CM–CKO
embryo, the contribution of the CM mesenchyme to the dorsal
peri-ocular tissue was lacking when comparing to the control
(Fig. 3N and O, n¼3). This deﬁciency in mesoderm-derived tissue
underpins the absence of the upper eyelid (Fig. 3O) and the failure
of eyelid closure in the E17.5 CM–CKO embryos.
Fig. 4. Myogenic differentiation of branchiomeric muscles is unaffected by the loss of Twist1 in the cranial mesoderm. (A-B) Mesp1-Cre; Rosa26R cells are located correctly
in the ﬁrst and second branchial arch of E10.5 CM–CKO embryos (black arrow, B), similar to the control (black arrow, A). (C–F) Correct initiation of myogenic
differentiation. The mesodermal core in the branchial arches of control and CM–CKO embryos show comparable levels of Tbx1 (black arrow, D) and Myf5 expression (F) in
the core tissues of the branchial arches of (C, D) E9.5 and (E, F) E11.5 embryos. The E9.5 CM–CKO embryo shows enhanced Tbx1 expression in the cranial paraxial
mesoderm (arrowhead, D). Myf5 is expressed in the peri-ocular region of control but not CM–CKO embryos at E11.5 (white arrowheads, E, F). (G, H) Differentiation of
muscle ﬁbers is not affected in CM–CKO embryo at E15.5, revealed by the presence of myosin heavy chain (MyHC) protein in the facial muscles (H, white arrow: extra
muscle masses are seen in this section of the mutant embryo, compared to the control (G). (I,J) In this example of the masticator muscles of the E17.5 CM–CKO embryo
(J) shows more loosely packed ﬁbers than (I) the control counterpart muscle (section plane: anterior to the otic capsule). Some muscles in the posterior head region are
related inappropriately with the surrounding skeletal elements that are also disoriented. Dashed lines mark the corresponding muscles in the control (K) and the CM–CKO
(L) embryos); br, brain; md, mandible; mx, maxilla; pt, pterygoid muscle; t, tongue; tm, temporal muscle. Scale bar¼100 mm.
Fig. 3. Impact of loss of Twist1 in the cranial mesoderm on the development of peri-ocular structures. (A, B) The extra-ocular muscles (eom) are severely underdeveloped in
the E17.5 CM–CKO embryo (B, black arrowhead), compared to the age-matched control (A). (C, D) Sparse and loosely organized myosin-heavy chain-positive ﬁbers in the
peri-ocular tissue of the E15.5 CM–CKO embryo (D), contrasting with the ﬁber bundles in the extraocular muscles of the control embryo (C, white arrowheads); the upper
eyelids of the CM–CKO embryo (D) are rudimentary and lack muscle ﬁbers. (E, F) In situ hybridization for Pitx2 expression at E10.5 showing reduced presence of Pitx2-
expressing cells in the CM–CKO embryo (F) in the area ventral to the eye invagination compared to control embryo (E, boxed area), indicating that the extraocular muscle
progenitor population is reduced. (G,H) Pitx2 expression is maintained (black arrow) in the ﬁrst and second branchial arches of the CM–CKO (I,J) Staining of Mesp1-Cre;
Rosa26R cells at E11.5.show a reduced population ofMesp1-Cre; Rosa26R positive mesoderm cells in the tissues surrounding the optic cup and the adjacent orbital area in the
CM–CKO (J) compared to the control (I, black arrow, muscle anlagen). (K,L) CM and CNC contribution to the eyelids at E11.0. The Wnt1-Cre; Rosa26R positive CNC cells
contributes to the tissues ventral to the eye primordium (asterisk, K) whereas the Mesp1-Cre; Rosa26R positive mesoderm cells to the tissues dorsal to the eye primordium
(L). (M–O) Lack of eyelid contribution from the Twist1 deﬁcient CM in the CM–CKO. The contribution of theWnt1-Cre; Rosa26R positive neural crest cells to the lower eyelid
(M), and tissues around the eye and in the neurocranium, compared to that of theMesp1-Cre; Rosa26R positive mesoderm cells, which contribute to the upper eyelid (black
arrow) and extraocular and facial muscles. At E13.5 (O) eyelids and extraocular muscles are absent in the CM–CKO embryo, and there is paucity of Mesp1-Cre; Rosa26R
positive mesoderm cells around the eye that is displaced deep in the head (O). ba1, 1st branchial arch; ba2, 2nd branchial arch e, eye; el, eyelid; mx, maxilla;
md, mandible; ov, optic vesicle. Scale bar¼100 mm.
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H. Bildsoe et al. / Developmental Biology 374 (2013) 295–307 301To test whether Twist1 expression was present only in the
progenitors or whether it is also maintained in mesoderm-
derived structures, we examined Twist1 and b-galactosidaseFig. 5. Altered tissue architecture of Twist1-deﬁcient cranial mesenchyme. (A–F) Stainin
the Mesp1-Cre; Rosa26R positive mesodermal cells are found, underlying the neural epit
region and are especially sparse in the medial region of the head folds (B and 5Bi. Black a
At E9.0 theTwist1-deﬁcient CM cells in the CM–CKO embryo exhibit multiple foci of c
mesenchymal appearance of the cranial mesoderm of the control embryo (C). Dashed b
exacerbated at E11.5 with the Mesp1-Cre; Rosa26R positive cells in the CM–CKO formin
not observed in the control (E). (G–L) Phalloidin staining to detect F-actin distribution (
cells in the CM–CKO adopt an epithelial morphology and is some cases display polari
E-cadherin (K, L); these epithelial characteristics are not observed in the cranial mesen
staining of cartilage elements. (M, N) Quantitative RT–PCR analysis of mesenchymal ge
E9.5 (N). At E8.5, no difference is observed between control and CM–CKO embryos,
*Po0.05 by two-tailed t-test, error bar¼s.e.m. n¼3 for all groups. ba, branchial arch; fgexpression by immunoﬂuorescence at E13.5. By this stage Twist1
was not detectable in the lacZ-positive developing EOM or
hypochiasmatic cartilage (Supplementary Fig. S3A, B, E–H), butg for Rosa26R activity in embryos at E8.5 (A-Bi), E9.0 (C, D) and E11.5 (E, F). At E8.5
helium (A and Ai). In the CM–CKO these cells are more tightly packed in the lateral
rrow in this ﬁgure Bi indicates clustered migrating cranial neural crest cells). (C–F)
ystic structure lined with a thin epithelium (arrows, D). This is in contrast to the
oxes indicate equivalent regions in control and CM–CKO tissue. This phenotype is
g compact tissue mass of epithelial-like structure with a central lumen (F). This is
G–I) and immunoﬂuorescence for E-cadherin (J–L) reveals that mesoderm-derived
zed apical-basal distribution of cytoskeletal F-actin (white arrow, H) and express
chyme of the control embryo (G, J). White asterisk in G and J indicates nonspeciﬁc
nes (Pdgfra, Snai2 and Vim) in control and CM–CKO embryo heads at E8.5 (M) and
whereas at E9.5, mesenchymal markers are down-regulated in CM–CKO tissues.
, foregut; fn, frontonasal; ne, neuroepithelium; ov, optic vesicle Scale bar¼100 mm.
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derived) tissues. In contrast, Twist1 expression was maintained in
mesoderm-derived tissues that form the skull and upper eyelid
(Supplementary Fig. 3A, D, E).
Whereas the extraocular muscles are derived from prechordal
head and paraxial mesoderm (Couly et al., 1992;Lescroart et al.,
2010), facial and jaw muscles are derived from the mesoderm of
the ﬁrst and second branchial arches [BA, (Depew et al., 2002)].
b-galactosidase positive mesoderm populated the core of the ﬁrst
(BA1) and second branchial arches (BA2) in both control and
CM–CKO embryos (Fig. 4A and B, n¼3). In addition to the
expression of Pitx2, Tbx1, a pre-myogenic marker detected in the
BA at E9.5, was expressed in the core of the BAs of the CM–CKO
embryo [Fig. 4C (Rinon et al., 2007)] and expression was elevated
in the tissues adjacent to the pharyngeal pouches in the CM–CKO
embryo [Fig. 4D, n¼3) (Rinon et al., 2007)]. At E11.5, Myf5
expression signiﬁed the onset of myogenic differentiation of the
ﬁrst branchial arch and periocular tissues in control embryos
(Fig. 4E). In CM–CKO embryos, Myf5 was expressed properly in
BA1 and BA2 but not in the periocular region, consistent with a
disruption of extraocular muscle development (Fig. 4E and F, n¼3).
BA-derived muscles were formed in the CM–CKO embryo at
E15.5 (n¼2) and E17.5 (n¼2; Fig. 4G and H, I and J). In CM–CKO
embryos muscles in the posterior region, including the pterygoid
(Fig. 4K and M) and the temporal muscles (Fig. 4K and M)
displayed abnormal patterning, presumably due to either lack of
or improper attachment to skeletal elements that were incor-
rectly positioned and shaped or completely absent.
Abnormal distribution of Twist1-deﬁcient mesoderm and acquisition
of epithelial characteristics
In control (Twist13loxPneo/wt, Mesp1Cre/þ , Rosa26R) and CM–CKO
embryos at E8.5, the majority of cells in the cranial mesenchyme
underneath the head folds were Mesp1-cre; Rosa26R positive
(Fig. 5A and B). However the head folds of the CM–CKO embryo
adopted a wide biconvex shape, instead of the elevated V-shapedFig. 6. Impact of the loss of Twist1 in the cranial mesoderm on cranial neural crest cells.
streams but are more widely spread in the CM–CKO embryo at E9.5 (B) compared to th
Rosa26R -positive mesodermal cells are clearly segregated from the trigeminal ganglio
border and intermingle with cells in the ganglion (black arrow). (E, F) H and E stainin
shape compared to the control (E) and is packed amongst an ectopic tissue mass (arr
pt, petrous part of temporal bone; t, tongue; tg, trigeminal ganglion. Scale bar¼100 mmconﬁguration seen in control embryos (Fig. 5Ai and Bi). In control
embryos, the mesoderm-derived cells ventral to the foregut
region were densely packed, while those underneath the neural
folds were loosely organized (Fig. 5Ai). In the CM–CKO embryos
fewer b-galactosidase positive mesodermal cells were found
underneath the neural plate while more cells were tightly
clustered in the lateral region of the head folds (Fig. 5Bi, n¼2).
Ki67 immunostaining revealed decreased cell proliferation in the
cranial mesoderm of E8.5 Twist1-deﬁcient embryos (2.65%7s.e.m
0.002, n¼4) compared to control (5.17%70.019, n¼3, p¼0.045
by two-tailed t-test; Supplementary Fig. S4A, B). Whole mount
TUNEL assay did not reveal elevated apoptosis in the cranial
mesenchyme of E8.5 CM–CKO embryos (Supplementary Fig. S4C
and D, n¼3) or E9.5 (Supplementary Fig. S4E and F, n¼3). To
further test whether enhanced apoptosis may underpin the
craniofacial phenotype, the effect of genetically ablating one or
both functional Trp53 alleles (thus reducing apoptotic activity) on
craniofacial development was examined in Twist1-null mutants,
which display the same open neural tube phenotype as CM–CKO
embryos. The craniofacial defects of Twist1-null embryos were
not rescued by loss of one or both functional alleles of Trp53,
suggesting that elevated cell death is unlikely to be a contributing
factor of the null-mutant phenotype (Supplementary Fig. S4G–J).
In E9.0 CM–CKO embryo, Mesp1-Cre; Rosa26R positive meso-
derm cells adjacent to the midbrain and upper hindbrain were
condensed and some were organized as cystic structures that
were not seen in the control embryos (Fig. 5C and D, black
arrows). By E11.5, this aberrant tissue phenotype was exacer-
bated as the densely packed mesenchyme formed clusters of
epithelial structures (Fig. 5E, F). The appearance of these epithelial
cyst-like structures suggests that the Twist1-deﬁcient mesench-
yme has acquired an atypical epithelial morphology, which is
reminiscent of mesenchymal-epithelial transition (MET). These
Rosa26R-positive structures were unlikely to have been derived
from the neuroepithelium or endoderm, which do not express
Mesp1-Cre or Twist1. Phalloidin staining revealed F-actin was
concentrated at the luminal side of the cells, highlighting an(A, B) Sox10-expressing neural crest cells remain segregated into pre- and post-otic
e control (A, dashed line). (C, D) Staining for Rosa26R activity showing that, while
n in the control embryo (C), those in the CM–CKO embryos (D) breach the tissue
g showing that the trigeminal ganglion of E17.5 CM–CKO (F) adopts an abnormal
ow). Abbreviations: br, brain; mp, medial pterygoid muscle; ne, neurepithelium;
.
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(Fig. 5G–I, n¼3). E-cadherin, which is present in adherens junc-
tions of epithelial cells, was also detected above background
levels in these epithelial-like cells (Fig. 5K–L, n¼3). A very low
level of E-cadherin was found in the mesenchyme of the control
embryo (Fig. 5J, n¼2). The Twist1-deﬁcient mesoderm also
showed a loss of mesenchymal properties with signiﬁcantly
reduced expression of Pdgfra and Snai2 in the cranial tissues of
E9.5 CM–CKO embryo coinciding with the appearance of the
atypical epithelialisation of the mesenchyme (Fig. 5M and N).
Together, the data indicate that Twist1-deﬁcient mesoderm cells
lose mesenchymal characteristics and gain epithelial properties.
Altered neural crest cell distribution in CKO embryos
In Twist1-null embryos that lack Twist1 activity in both the CM
and the CNC derivatives, migration of the CNC cells is affected and
the patterning of the CNC-derived cranial ganglia is disrupted
(Ota et al., 2004; Soo et al., 2002). In control embryos (Twist13loxP-
neo/wt, Mesp1Cre/þ , Rosa26R), the unlabeled CNC cells were evenly
distributed in the subectodermal region between the neural folds
and the branchial arches (Fig. 5Ai). In contrast, the CNCs in the CM–
CKO embryos clustered together in the space between the neural
fold and dorsal surface ectoderm (Fig. 5Bi). In the CM–CKO
embryos, Sox10-positive CNC cells of the anterior (pre-otic) and
the posterior (post-otic) streams remained separate as in the
control embryos, but both Sox10 positive streams appeared to
spread to a wider domain (Fig. 6A and B, compare dashed lines
n¼3). At E17.5, the trigeminal ganglion was localized adjacent to
part of the temporal bone in both the control and the CM–CKO
embryos (Fig. 6E and F). However the ganglion of the CM–CKO
embryos had an abnormal shape and the arrangement of skeletal
elements around the ganglion was disorganized (Fig. 6E and F, black
arrow). In E11.5 control embryos, CNC- derived trigeminal ganglion
consisting mostly of unlabeled cells was clearly segregated from theFig. 7. The functional roles of Twist1 in craniofacial development. Twist1 is required to s
to form the skull vault, base and frontonasal region including the upper jaw and th
mesenchymal architecture and proliferative capacity, which secondarily inﬂuences the m
neural tube morphogenesis offers the morphogenetic options for the cranial neural cres
the bones in the skull vault is also dependent on the reciprocal interactions of these tsurrounding b-galactosidase positive mesoderm-derived mesench-
yme (Fig. 6C), whereas in CM–CKO embryos, Rosa26R positive cells
intermingled with the Rosa26R negative cells (Fig. 6D). While no
mesoderm-derived cells were localized inappropriately in the CNC-
derived skeletal tissues, there was an increased contribution of b-
galactosidase positive cells to the neuroepithelium (Fig. 3O,
Supplementary Fig. S5). These invading cells could be endothelial,
but the appearance and cellular arrangement of some clusters are
reminiscent of the radial distribution of ES cell-derived neural
progenitors that was observed in chimeric embryos (Tan et al.,
1998). The intrusion of Twist1-deﬁcient mesodermal cells to the
CNC-derived tissues and the neurectoderm points to the possibility
of a failure of the ability to segregate the mesoderm derivatives
from other cranial tissues during morphogenesis.Discussion
Twist1 is required for maintaining mesenchymal tissue architecture
In the present study, we have uncovered a mesoderm-speciﬁc
requirement for Twist1, which differs from its role in the CNC
(Fig. 7). Although the Twist1 transcript can be detected in the
mesoderm during gastrulation (this study; Fuchtbauer, 1995;
Stoetzel et al., 1995), Twist1 protein was not detectable until
the 2-somite stage. At this stage, the mesenchymal cells are
evenly distributed in the cephalic region in wild-type embryos.
In CM–CKO embryos, the earliest defect that could be detected
was a loss of the normal mesenchymal properties, initially
revealed by changes in cell density and later a tendency to
undergo a transition to an epithelial architecture. This indicates
a failure to properly maintain the cells in a mesenchymal
progenitor state. At E9.0, localized clumps of Mesp1-Cre; Rosa26R
positive cells were found in the cranial mesoderm, and some
compacted clusters acquired an epithelial cystic morphology. Thisustain the viability and the regionalization of the cranial neural crest cells destined
e cranial ganglia. In the cranial mesoderm, Twist1 is required to maintain the
igration of the cranial neural crest cells and the closure of the neural tube. Normal
t cells and the mesoderm to localize to the sites of the skull vault. The formation of
wo cell types which is dependent on Twist1 activity in both cell populations.
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epithelial to mesenchymal cell morphology. Activation of Twist1
expression is known to play a role in inducing epithelial–
mesenchymal transition (EMT), and overexpression of Twist1
has been associated with the metastatic behavior of tumor cells
(Karreth and Tuveson, 2004; Qin et al., 2012; Wu, 2011). This may
be mediated either directly by the interaction of Twist1 with the
regulatory element of E-cadherin to repress its expression (Yang
et al., 2004; Yang et al., 2007) (Fu et al., 2011) or through
activation of Snail2 gene expression, which is also known to
repress E-cadherin (Casas et al., 2011). Reversion of EMT has been
demonstrated in Twist1-depleted gastric cancer cells (Feng et al.,
2009). To the best of our knowledge, the present study provides
the ﬁrst demonstration that Twist1 is required for the mainte-
nance of mesenchymal properties of mesoderm cells during
embryonic development. Consistent with the concept that loss
of Twist1 activity can lead to the acquisition of epithelial char-
acteristics, expression of E-cadherin was up-regulated in these de
novo epithelial structures in the CM–CKO embryo, whilst Pdgrfa
and Snai2 were down-regulated. The inability to maintain the
expression of these mesenchymal speciﬁc genes and the repres-
sion of E-cadherin in the absence of Twist1 expression might
account for this aberrant behavior of the Twist1-deﬁcient
mesenchyme.
Tissue-speciﬁc effect of loss of Twist1 function on neural tube closure
Previously we have shown that ablation of Twist1 in the CNC
results in increased apoptosis and a reduced capacity for the
remaining cells to initiate osteogenic differentiation [Fig. 7, upper
part (Bildsoe et al., 2009; Ota et al., 2004)]. The combination of
these effects may account for the loss of CNC-derived skeletal
structures in CNC conditional mutant embryos (Bildsoe et al.,
2009). In contrast, loss of Twist1 in the early cranial mesoderm
has no effect on apoptosis but leads to less cell proliferation,
suggesting that the population of mesoderm progenitors may be
reduced (Fig. 7 lower part). In addition to a paucity of mesench-
ymal cells underneath the neural plate, the bulk of them are
sequestered away from to the surface ectoderm and they are
densely packed with very little extracellular space, suggesting
that the ECM may be deﬁcient. This change in the mesenchyme
characteristics may have a secondary impact on the closure of the
neural tube. The cranial mesenchyme is known to be essential for
supporting neural tube formation. The morphogenetic forces
generated by the increasing rigidity and the volume of the
mesenchyme due to expansion of the hyaluronate-enriched
extracellular matrix (ECM) can facilitate the elevation and folding
of the neural plate (Morris-Wiman and Brinkley, 1990). Since the
neural tube closure is unaffected by the loss of Twist1 in the
cranial neural crest cells, the lack of growth or ECM expansion of
the Twist1-deﬁcient cranial mesenchyme is therefore likely to
directly impact on the closure of the neural tube (Fig. 7, and see
Zohn and Sarkar, 2012).
Loss of Twist1 in the mesoderm results in defects of both mesodermal
and neural crest-derived bones
In this study, we have shown that tissue speciﬁc deletion of
Twist1 leads to a loss or reduction of mesoderm-derived bones as
well as some CNC-derived skull vault elements (Fig. 8A, C). It is
unclear whether the loss of Twist1 function affects the differentia-
tion of membranous bones resulting in malformation of the CM
derived skeletal elements, or this is due to a secondary affect
caused by the failure of neural tube closure creating a physical
hindrance that disrupts the correct localization of the skull
progenitor tissues in the head. The brain lacks a covering ofmesoderm-derived cells. Instead, large aggregates of Mesp1-Cre;
Rosa26R-positive cells was observed in the regions lateral to the
occipital part of the head. The precise origin and fate of these
Twist1-deﬁcient mesoderm cells are not known, but it is possible
that they are bone precursor cells that failed to localize to the
appropriate sites and did not receive the proper inductive inter-
actions for bone formation. Loss of Twist1 also affects mesoderm-
derived bones in the skull base, leading to reduced size and
abnormal shape of the bones and, in the case of the basioccipital,
its mis-alignment with the skull base. These abnormalities are
unlikely to be due to any physical hindrance to cell localization.
Twist1 is known to negatively modulate the progression of
chondrogenesis and osteogenesis and to maintain the mesench-
ymal cells in an immature state in vitro (Dong et al., 2007;
Miraoui et al., 2010; Miraoui and Marie, 2010). Twist1 also
interacts with Sox9 and Runx2 to inhibit their action in chondro-
genesis and osteoblast differentiation respectively (Bialek et al.,
2004; Gu et al., 2012; Rice et al., 2000). The maintenance of the
immature state is likely to be a prerequisite for maintaining the
capacity to differentiate, since differentiation of Twist1-deﬁcient
CNC cells is impaired in conditional knockout embryos (Bildsoe
et al., 2009).
The impact of loss of Twist1 in the mesoderm also affects skull
bones derived from the CNC cells such as the frontal bone, which
was greatly reduced in size (Fig. 8C). This is consistent with an
indirect effect due to the physical barrier created by the failure to
close the cranial neural tube, preventing the bone precursors from
forming proper frontal bones. However, previous studies have
shown that Twist1 is required for interactions between the
mesoderm and the CNC cells. In embryos in which Twist1 was
ablated in the CNC (Bildsoe et al., 2009), loss of skull elements
also encompasses those of mesoderm origin (such as the parietal,
interparietal and supraoccipital bones; Fig. 8B). This is most likely
due to the lack of inductive interactions between CNC-derived
meninges, which are lost in the absence of Twist1, and the
mesodermal bone progenitors (Gagan et al., 2007). Twist1 may
also mediate the inﬂuence of the mesoderm on migratory CNC
cells. Cell transplantation experiments (Soo et al., 2002) have
shown that wild-type CNC cells were less efﬁcient in homing to
the branchial arches in the Twist1-null host embryos. In the
present study, we observed that migrating CNC cells occupied a
wider domain in CKO embryos and that the mesoderm cells
breached the boundary between the mesenchyme and the CNC-
derived ganglia and intermingled with the cells of the ganglion.
Collectively, these ﬁndings suggest Twist1 may be required for
proper osteogenic differentiation of both CM and CNC cells, and
that the loss of gene function in one tissue may affect the other
due to the disruption of the reciprocal tissue interactions.Development of peri-ocular structures is affected by loss of Twist1
in the mesoderm
A negative correlation between Twist1 expression and myoblast
differentiation has been observed in muscle development
(Koutsoulidou et al., 2011). Twist1 can dimerize competitively with
other basic helix–loop–helix proteins such as MyoD preventing them
from binding with E-proteins and inhibiting the trans-activation of
downstream targets, suppressing myogenesis (Franco et al., 2011;
Spicer et al., 1996). In the absence of Twist1 activity in the
mesoderm, there was no negative effect on myogenic differentiation.
Branchial arch (BA)-derived muscles of appropriate histology and
molecular characteristics were formed in the CM–CKO embryos.
However, the arrangement of the muscles differs from that in the
wild type embryo. This may be related to the absence and misplace-
ment of the skull elements to which the muscles are attached.
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Fig. 8. The impact of loss of Twist1 function on the formation of skull bones. (A) Components of the neurocranium and viscerocranium that are derived predominantly from
cranial neural crest (CNC) and cranial mesoderm (CM) respectively. CNC cells give rise to the entire viscerocranium (upper and lower jaw and the nasal region) and to the
anterior part of the skull vault and base (blue elements), whereas the CM make up the posterior elements of the skull vault and base (pink elements). (B) Skull bones that
are affected by the loss of Twist1 in the CNC cells. Most severely affected are the elements of the CNC-derived viscerocranium and the frontal bones, which are either absent
or reduced in size. In addition, CM-derived bone such as the parietal and interparietal bones are also affected. (C) Loss Twist1 in the CM leads to absence of parietal,
interparietal, supraoccipital and suprachiasmatic bones and deformation of skull base bones, as well as the drastically reduced or lost CNC-derived frontal bones.
Abbreviations: ap, angular process; as, alisphenoid; bo, basioccipital; bs, basisphenoid; d, dentary; eo, exoccipital; f, frontal; in, incus; ip, interparietal; m, maxilla; ma,
malleus; mc, Meckel’s cartilage; n, nasal; nc, nasal capsule; ns, nasal septum; p, parietal; pm, premaxilla; pp, parietal plate; ps, prespenoid; pt, petrous part of temporal
bone; so, supraoccipital; sp, styloid process; sq, squamous; tb, trabecular basal plate; tr, tympanic ring; zp, zygomatic process. Data are collated from Bildsoe et al., 2009
and this study.
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severely impaired in CM–CKO mutant embryos.
EOM are derived from prechordal mesoderm with additional
contributions from the cranial paraxial mesoderm, whereas the
BA-derived muscle mainly originate from lateral parts of the
cranial mesoderm (Lescroart et al., 2010; Noden and Francis-
West, 2006; Sambasivan et al., 2011b). One of the elements in the
peri-orbital skeleton is the hypochiasmatic cartilage, which
develops as an isolated mesoderm-derived structure embedded
in the CNC-derived anterior skull base. This cartilage forms a
bridge between the orbital cartilage and the skull base, to which
the EOM attaches. It has been proposed, based on their spatial
association, that the EOM and the hypochiasmatic cartilage share
a common origin in the anterior cranial mesoderm (McBratney-
Owen et al., 2008). At E9.5, Twist1 is no longer expressed in the
mesoderm cells in the core of the branchial arches, which have
initiated myogenic differentiation (Rinon et al., 2007) but Twist1
expression is sustained in the tissues in other parts of the CM at
this stage, including the region that is likely to contain theprogenitors of the EOMs. Twist1 expression is also maintained in
a cell line derived from EOM, but not in a skeletal muscle-derived
cell line (Porter et al., 2006). Our Rosa26R reporter results show
that the poor development or absence of EOM may be caused by a
reduction of the progenitor population. Absence of Twist1 activity
in the peri-ocular tissue may lead to the failure to maintain the
progenitors prior to the formation of the EOMs and the hypo-
chiasmatic cartilage. This scenario is consistent with the concept
that the function of Twist1 is to maintain the progenitor state of
the mesoderm cells and thereby control the initiation of lineage
differentiation.Acknowledgments
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